HIV News
FDA Approves First Extended-Release Injectable Regimen for Adults Living with HIV
The U.S. Food and Drug Administration approved Cabenuva as a complete regimen for the treatment of HIV-1 infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance Read more…